BioCentury
ARTICLE | Clinical News

Voretigene neparvovec: Additional Phase III data

August 15, 2016 7:00 AM UTC

Data from 9 patients with inherited retinal dystrophies due to confirmed RPE65 gene mutations who crossed over from the untreated control arm of the open-label, U.S. Phase III trial showed that voreti...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article